Company intelligence / Profile preview

Techcyte

Orem, Utah, United Statestechcyte.com ↗

Ownership: Private
Employees: ~120
Development stage: Commercial

Overview

Techcyte has delivered over five million clinical AI diagnoses across human, veterinary, and environmental health. Its algorithms are CE-IVDD marked in Europe and used globally for applications such as cervical cancer screening, blood differential analysis, bacteriology gram analysis, non-invasive bladder cancer detection, fecal ova & parasite detection. The company is pursuing further clinical studies toward FDA submission in the US[3][4].

Therapeutic areas: OncologyHematologyInfectious Diseases
Modalities: Device (AI-powered digital diagnostics platform)Software (AI/ML algorithms for pathology)
Industry: Pathology

Partnerships

Mayo Clinic Platform[1]BD/Becton Dickinson[1]Pramana[1]Aiosyn[6]Zoetis (veterinary diagnostics)[4]

Beyond the preview

Go deeper on Techcyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Techcyte.

Explore the full profile